Insider Trading & Ownership - CytomX Therapeutics Inc. (CTMX)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for CytomX Therapeutics Inc.
Goto Prev, 0, 1, 2, 3, Next
Common stock purchase or sale:
Transaction
Date		 Reported
DateTime		 Company Symbol Insider
Relationship		 Shares
Traded		 Average
Price		 Total
Amount		 Shares
Owned		 Filing
2023-12-20
Sale		 2023-12-22
4:16 pm		 CytomX Therapeutics Inc. CTMX McCarthy Sean A.
CEO		 13,551 $1.3807 $18,710 547,862
(Indirect
Direct)		 View
2023-12-20
Sale		 2023-12-22
4:14 pm		 CytomX Therapeutics Inc. CTMX BELVIN MARCIA
SVP, Chief Scientific Officer		 4,077 $1.3805 $5,628 155,124
(Direct)		 View
2023-12-20
Sale		 2023-12-22
4:12 pm		 CytomX Therapeutics Inc. CTMX Landau Jeffrey B
Chief Business Officer		 4,077 $1.3805 $5,628 94,302
(Indirect
Direct)		 View
2023-12-20
Sale		 2023-12-22
4:11 pm		 CytomX Therapeutics Inc. CTMX ROWLAND LLOYD A
General Counsel		 4,077 $1.3807 $5,629 97,996
(Direct)		 View
2023-12-20
Sale		 2023-12-22
4:10 pm		 CytomX Therapeutics Inc. CTMX Ogden Christopher
SVP, Finance and Accounting		 1,990 $1.3806 $2,747 48,657
(Direct)		 View
2023-09-22
Sale		 2023-09-22
7:16 pm		 CytomX Therapeutics Inc. CTMX BELVIN MARCIA
SVP, Chief Scientific Officer		 4,119 $1.3003 $5,356 147,951
(Direct)		 View
2023-09-22
Sale		 2023-09-22
7:15 pm		 CytomX Therapeutics Inc. CTMX Landau Jeffrey B
Chief Business Officer		 4,119 $1.3003 $5,356 84,059
(Indirect
Direct)		 View
2023-09-22
Sale		 2023-09-22
7:13 pm		 CytomX Therapeutics Inc. CTMX McCarthy Sean A.
CEO		 14,601 $1.3004 $18,987 523,913
(Indirect
Direct)		 View
2023-09-22
Sale		 2023-09-22
7:12 pm		 CytomX Therapeutics Inc. CTMX ROWLAND LLOYD A
General Counsel		 5,486 $1.3006 $7,135 80,609
(Direct)		 View
2023-03-29
Purchase		 2023-03-31
7:56 pm		 CytomX Therapeutics Inc. CTMX Jones Elaine V
Director		 5,000 $1.55 $7,750 5,142
(Direct)		 View
2023-03-16
Sale		 2023-03-20
6:43 pm		 CytomX Therapeutics Inc. CTMX Ogden Christopher
SVP, Finance and Accounting		 516 $1.9793 $1,021 37,772
(Direct)		 View
2023-03-16
Sale		 2023-03-20
6:43 pm		 CytomX Therapeutics Inc. CTMX McCarthy Sean A.
CEO		 7,121 $1.8805 $13,391 481,979
(Indirect
Direct)		 View
2023-03-16
Sale		 2023-03-20
6:43 pm		 CytomX Therapeutics Inc. CTMX Campoy Carlos
Chief Financial Officer		 1,748 $1.9791 $3,459 38,224
(Direct)		 View
2023-03-16
Sale		 2023-03-20
6:43 pm		 CytomX Therapeutics Inc. CTMX ROWLAND LLOYD A
General Counsel		 2,037 $1.979 $4,031 71,095
(Direct)		 View
2023-03-16
Sale		 2023-03-20
6:43 pm		 CytomX Therapeutics Inc. CTMX Landau Jeffrey B
Chief Financial Officer		 1,477 $1.9792 $2,923 76,928
(Indirect
Direct)		 View
2023-03-16
Sale		 2023-03-20
6:43 pm		 CytomX Therapeutics Inc. CTMX Peterson Amy C.
EVP, Chief Development Officer		 4,257 $1.979 $8,425 58,433
(Direct)		 View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date		 Reported
DateTime		 Exercisable
Expiration		 Company Symnbol Insider
Relationship		 Shares
Traded		 Conversion
Price		 Shares
Owned		 Filing
2024-01-18
Option Award		 2024-01-19
8:41 pm		 N/A
2034-01-17		 CytomX Therapeutics Inc. CTMX Ogden Christopher
SVP, Finance and Accounting		 269,000 $0 317,657
(Direct)		 View
2024-01-18
Option Award		 2024-01-19
8:40 pm		 N/A
2034-01-17		 CytomX Therapeutics Inc. CTMX Landau Jeffrey B
Chief Business Officer		 245,000 $0 339,302
(Direct)		 View
2024-01-18
Option Award		 2024-01-19
8:38 pm		 N/A
2034-01-17		 CytomX Therapeutics Inc. CTMX BELVIN MARCIA
SVP, Chief Scientific Officer		 223,750 $0 378,874
(Direct)		 View
2024-01-18
Option Award		 2024-01-19
8:37 pm		 N/A
2034-01-17		 CytomX Therapeutics Inc. CTMX Chu Yu-Waye
Chief Medical Officer		 223,750 $0 223,750
(Direct)		 View
2023-12-17
Exercise		 2023-12-19
7:58 pm		 N/A
N/A		 CytomX Therapeutics Inc. CTMX Ogden Christopher
SVP, Finance and Accounting		 6,875 $0 57,522
(Direct)		 View
2023-12-17
Exercise		 2023-12-19
7:57 pm		 N/A
N/A		 CytomX Therapeutics Inc. CTMX McCarthy Sean A.
CEO		 37,500 $0 598,913
(Direct)		 View
2023-12-17
Exercise		 2023-12-19
7:56 pm		 N/A
N/A		 CytomX Therapeutics Inc. CTMX Landau Jeffrey B
Chief Business Officer		 11,250 $0 109,629
(Direct)		 View
2023-12-17
Exercise		 2023-12-19
7:55 pm		 N/A
N/A		 CytomX Therapeutics Inc. CTMX ROWLAND LLOYD A
General Counsel		 11,250 $0 113,323
(Direct)		 View
2023-12-17
Exercise		 2023-12-19
7:54 pm		 N/A
N/A		 CytomX Therapeutics Inc. CTMX BELVIN MARCIA
SVP, Chief Scientific Officer		 11,250 $0 170,451
(Direct)		 View
2023-09-20
Option Award		 2023-09-22
7:16 pm		 N/A
N/A		 CytomX Therapeutics Inc. CTMX BELVIN MARCIA
SVP, Chief Scientific Officer		 11,250 $0 147,951
(Direct)		 View
2023-09-20
Option Award		 2023-09-22
7:15 pm		 N/A
N/A		 CytomX Therapeutics Inc. CTMX Landau Jeffrey B
Chief Business Officer		 11,250 $0 84,059
(Direct)		 View
2023-09-20
Option Award		 2023-09-22
7:13 pm		 N/A
N/A		 CytomX Therapeutics Inc. CTMX McCarthy Sean A.
CEO		 40,000 $0 523,913
(Direct)		 View
2023-09-20
Option Award		 2023-09-22
7:12 pm		 N/A
N/A		 CytomX Therapeutics Inc. CTMX ROWLAND LLOYD A
General Counsel		 15,000 $0 80,609
(Direct)		 View
2023-07-19
Option Award		 2023-07-20
5:18 pm		 N/A
2033-07-18		 CytomX Therapeutics Inc. CTMX Chu Yu-Waye
Chief Medical Officer		 375,000 $0 375,000
(Direct)		 View
2023-06-14
Option Award		 2023-06-16
5:54 pm		 N/A
2033-06-13		 CytomX Therapeutics Inc. CTMX Meyers James R
Director		 25,000 $0 25,000
(Direct)		 View
2023-06-14
Option Award		 2023-06-16
5:52 pm		 N/A
2033-06-13		 CytomX Therapeutics Inc. CTMX Mohindru Mani
Director		 25,000 $0 25,000
(Direct)		 View
2023-06-14
Option Award		 2023-06-16
5:51 pm		 N/A
2033-06-13		 CytomX Therapeutics Inc. CTMX Young Matthew P.
Director		 25,000 $0 25,000
(Direct)		 View
2023-06-14
Option Award		 2023-06-16
5:50 pm		 N/A
2033-06-13		 CytomX Therapeutics Inc. CTMX Ashworth Alan
Director		 25,000 $0 25,000
(Direct)		 View
2023-06-14
Option Award		 2023-06-16
5:49 pm		 N/A
2033-06-13		 CytomX Therapeutics Inc. CTMX Gilbert Halley E
Director		 25,000 $0 25,000
(Direct)		 View
2023-06-14
Option Award		 2023-06-16
5:49 pm		 N/A
2033-06-13		 CytomX Therapeutics Inc. CTMX Jones Elaine V
Director		 25,000 $0 25,000
(Direct)		 View
2023-05-19
Exercise		 2023-05-23
4:52 pm		 N/A
2025-02-08		 CytomX Therapeutics Inc. CTMX McCarthy Sean A.
CEO		 16,535 $0 618,050
(Direct)		 View
2023-05-19
Exercise		 2023-05-23
4:52 pm		 N/A
N/A		 CytomX Therapeutics Inc. CTMX McCarthy Sean A.
CEO		 16,535 $1.5749 618,050
(Direct)		 View
2023-03-22
Option Award		 2023-03-29
7:54 pm		 N/A
N/A		 CytomX Therapeutics Inc. CTMX BELVIN MARCIA
SVP, Chief Scientific Officer		 60,000 $0 140,820
(Direct)		 View

Ownership		 2023-03-29
7:50 pm		 N/A
N/A		 CytomX Therapeutics Inc. CTMX BELVIN MARCIA
SVP, Chief Scientific Officer		 0 $0 881,310
(Direct)		 View
2023-02-02
Option Award		 2023-02-06
4:50 pm		 N/A
2033-02-01		 CytomX Therapeutics Inc. CTMX McCarthy Sean A.
CEO		 720,000 $0 1,104,100
(Direct)		 View
2023-02-02
Option Award		 2023-02-06
4:49 pm		 N/A
2033-02-01		 CytomX Therapeutics Inc. CTMX Landau Jeffrey B
Chief Business Officer		 215,000 $0 253,405
(Direct)		 View
2023-02-02
Option Award		 2023-02-06
4:48 pm		 N/A
2033-02-01		 CytomX Therapeutics Inc. CTMX ROWLAND LLOYD A
General Counsel		 175,000 $0 223,132
(Direct)		 View
2023-02-02
Option Award		 2023-02-06
4:47 pm		 N/A
2033-02-01		 CytomX Therapeutics Inc. CTMX Ogden Christopher
SVP, Finance and Accounting		 175,000 $0 188,288
(Direct)		 View
Goto Prev, 0, 1, 2, 3, Next